105 related articles for article (PubMed ID: 22278826)
21. Inhibition of mTORC1 inhibits lytic replication of Epstein-Barr virus in a cell-type specific manner.
Adamson AL; Le BT; Siedenburg BD
Virol J; 2014 Jun; 11():110. PubMed ID: 24917448
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the Epstein-Barr virus Zp promoter in B lymphocytes during reactivation from latency.
McDonald C; Karstegl CE; Kellam P; Farrell PJ
J Gen Virol; 2010 Mar; 91(Pt 3):622-9. PubMed ID: 19923262
[TBL] [Abstract][Full Text] [Related]
23. The expression of the Epstein-Barr virus nuclear antigen (EBNA-I) in oral hairy leukoplakia.
Cruchley AT; Murray PG; Niedobitek G; Reynolds GM; Williams DM; Young LS
Oral Dis; 1997 May; 3 Suppl 1():S177-9. PubMed ID: 9456684
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 alter mitochondrial morphology during lytic replication.
LaJeunesse DR; Brooks K; Adamson AL
Biochem Biophys Res Commun; 2005 Jul; 333(2):438-42. PubMed ID: 15950179
[TBL] [Abstract][Full Text] [Related]
26. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.
Kudoh A; Fujita M; Kiyono T; Kuzushima K; Sugaya Y; Izuta S; Nishiyama Y; Tsurumi T
J Virol; 2003 Jan; 77(2):851-61. PubMed ID: 12502801
[TBL] [Abstract][Full Text] [Related]
27. Aryl hydrocarbon receptor-mediated induction of EBV reactivation as a risk factor for Sjögren's syndrome.
Inoue H; Mishima K; Yamamoto-Yoshida S; Ushikoshi-Nakayama R; Nakagawa Y; Yamamoto K; Ryo K; Ide F; Saito I
J Immunol; 2012 May; 188(9):4654-62. PubMed ID: 22467650
[TBL] [Abstract][Full Text] [Related]
28. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
[TBL] [Abstract][Full Text] [Related]
29. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
[TBL] [Abstract][Full Text] [Related]
31. Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter.
Lavens S; Faust EA; Lu F; Jacob M; Leta M; Lieberman PM; Puré E
J Virol; 2004 Aug; 78(16):8543-51. PubMed ID: 15280463
[TBL] [Abstract][Full Text] [Related]
32. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus type 1 infection activates the Epstein-Barr virus replicative cycle via a CREB-dependent mechanism.
Wu H; Li T; Zeng M; Peng T
Cell Microbiol; 2012 Apr; 14(4):546-59. PubMed ID: 22188237
[TBL] [Abstract][Full Text] [Related]
34. BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha.
Long X; Li Y; Yang M; Huang L; Gong W; Kuang E
J Virol; 2016 Sep; 90(17):7880-93. PubMed ID: 27334596
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
Longnecker R
Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681
[TBL] [Abstract][Full Text] [Related]
37. Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state.
Prang NS; Hornef MW; Jäger M; Wagner HJ; Wolf H; Schwarzmann FM
Blood; 1997 Mar; 89(5):1665-77. PubMed ID: 9057649
[TBL] [Abstract][Full Text] [Related]
38. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
[TBL] [Abstract][Full Text] [Related]
40. Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo.
Walling DM; Flaitz CM; Nichols CM; Hudnall SD; Adler-Storthz K
J Infect Dis; 2001 Dec; 184(12):1499-507. PubMed ID: 11740724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
